This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Lipid Nanoparticle Formulations. Top assignees: Acuitas Therapeutics, Inc., Dermira (Canada), Inc., Alnylam Pharmaceuticals, Inc.. Active years: 2003-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2016)
- Richmond, CA (2003 - 2023)
- Vancouver, CA (2023)
Company Filing History:
17 out of 28 
2 out of 6 
1 out of 466 
Years Active: 2003-2023
Areas of Expertise:
Title: Xinyao Du – Pioneer in Lipid Nanoparticle Formulations
Introduction
Xinyao Du, based in Richmond, CA, is an accomplished inventor with a remarkable portfolio of 24 patents. His work primarily focuses on the innovative development of lipid nanoparticle formulations aimed at enhancing the delivery of therapeutic agents, particularly nucleic acids.
Latest Patents
Among his latest patents, Du has contributed significantly to the field with innovations such as "Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids." These compounds are designed with specific structural properties, providing a platform for advanced therapeutic delivery. The patent describes methods for utilizing these compounds in lipid nanoparticle formulations, wherein they serve as essential components for the effective delivery of therapeutic agents. Additionally, Du’s patent on improved lipid nanoparticle formulations enhances the performance and efficacy of these carriers, proving invaluable in the realm of medical therapies.
Career Highlights
Throughout his career, Xinyao Du has worked with notable companies such as Acuitas Therapeutics, Inc. and Dermira, Inc. His contributions to these organizations have played a crucial role in advancing lipid-based therapies. His extensive work in this specialized field has earned him recognition among peers and industry leaders alike.
Collaborations
Du has collaborated with esteemed colleagues, including Steven Michial Ansell and Zaihui Zhang. These collaborations reflect his commitment to fostering innovation and achieving breakthroughs in pharmaceutical technology, further solidifying his position as a leading figure in his area of expertise.
Conclusion
Xinyao Du's extensive patent portfolio and collaborative efforts underscore his significant impact on the advancements in lipid nanoparticle formulations and therapeutic delivery systems. His innovative spirit and dedication to research continue to pave the way for future developments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile